Apc mice: Models, modifiers and mutants

Pathology Research and Practice

Volumn 204, Issue 7, 2008, Pages 479-490

  McCart, Amy E ^a   Vickaryous, Nicola K ^a   Silver, Andrew ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apc; Colorectal cancer; Min; Mom; Mouse

Indexed keywords

APC PROTEIN; CELECOXIB; CRE RECOMBINASE; MUTANT PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SULINDAC;

ADENOMATOUS POLYP; ADVANCED CANCER; ARTICLE; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CANCER RISK; CHROMOSOMAL INSTABILITY; CLINICAL TRIAL; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; DNA DAMAGE; DNA REPAIR; EPIGENETICS; FAMILIAL DISEASE; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE LOSS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC STABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; METASTASIS POTENTIAL; MICROSATELLITE INSTABILITY; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PROSTAGLANDIN SYNTHESIS; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; GENOMIC INSTABILITY; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS;

EID: 46749111024     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.03.004     Document Type: Article

References (84)

1. Alberici P., Jagmohan-Changur S., De Pater E., Van Der Valk M., Smits R., Hohenstein P., and Fodde R. Smad4 haploinsufficiency in mouse models for intestinal cancer. Oncogene 25 (2006) 1841-1851
2. Andreu P., Colnot S., Godard C., Gad S., Chafey P., Niwa-Kawakita M., Laurent-Puig P., Kahn A., Robine S., Perret C., and Romagnolo B. Cryptrestricted proliferation and commitment to the paneth cell lineage following Apc loss in the mouse intestine. Development 132 (2005) 1443-1451
3. Aoki K., Tamai Y., Horiike S., Oshima M., and Taketo M.M. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat. Genet. 35 (2003) 323-330
4. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N., Flavell R.A., and Liskay R.M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82 (1995) 309-319
5. Baker S.M., Harris A.C., Tsao J.L., Flath T.J., Bronner C.E., Gordon M., Shibata D., and Liskay R.M. Enhanced intestinal adenomatous polyp formation in Pms2-/-; Min mice. Cancer Res. 58 (1998) 1087-1089
6. Baran A.A., Silverman K.A., Zeskand J., Koratkar R., Palmer A., McCullen K., Curran Jr. W.J., Edmonston T.B., Siracusa L.D., and Buchberg A.M. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res. 17 (2007) 566-576
7. Batlle E., Bacani J., Begthel H., Jonkheer S., Gregorieff A., van de Born M., Malats N., Sancho E., Boon E., Pawson T., Gallinger S., Pals S., and Clevers H. EphB receptor activity suppresses colorectal cancer progression. Nature 435 (2005) 1126-1130
8. Beazer-Barclay Y., Levy D.B., Moser A.R., Dove W.F., Hamilton S.R., Vogelstein B., and Kinzler K.W. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 17 (1996) 1757-1760
9. Boivin G.P., Washington K., Yang K., Ward J.M., Pretlow T.P., Russell R., Besselsen D.G., Godfrey V.L., Doetschman T., Dove W.F., Pitot H.C., Halberg R.B., Itzkowitz S.H., Groden J., and Coffey R.J. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124 (2003) 762-777
10. Caldwell C.M., Green R.A., and Kaplan K.B. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J. Cell Biol. 178 (2007) 1109-1120
11. Cho N.L., Javid S.H., Carothers A.M., Redston M., and Bertagnolli M.M. Estrogen receptors alpha and beta are inhibitory modifiers of Apc dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res. 67 (2007) 2366-2372
12. Chulada P.C., Thompson M.B., Mahler J.F., Doyle C.M., Gaul B.W., Lee C., Tiano H.F., Morham S.G., Smithies O., and Langenbach R. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res. 60 (2000) 4705-4708
13. Colnot S., Niwa-Kawakita M., Hamard G., Godard C., Le Plenier S., Houbron C., Romagnolo B., Berrebi D., Giovannini M., and Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest. 84 (2004) 1619-1630
14. Cormier R.T., Bilger A., Lillich A.J., Halberg R.B., Hong K.H., Gould K.A., Borenstein N., Lander E.S., and Dove W.F. The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 19 (2000) 3182-3192
15. Dietrich W.F., Lander E.S., Smith J.S., Moser A.R., Gould K.A., Luongo C., Borenstein N., and Dove W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75 (1993) 631-639
16. Eads C.A., Nickel A.E., and Laird P.W. Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc (Min/+) Dnmt1-hypomorphic mice. Cancer Res. 62 (2002) 1296-1299
17. Edelmann W., Cohen P.E., Kane M., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard J.W., Kolodner R.D., and Kucherlapati R. Meiotic pachytene arrest in MLH1-deficient mice. Cell 85 (1996) 1125-1134
18. 1638N mutant mice. Cancer Res. 59 (1999) 1301-1307
19. Edelmann W., Umar A., Yang K., Heyer J., Kucherlapati M., Lia M., Kneitz B., Avdievich E., Fan K., Wong E., Crouse G., Kunkel T., Lipkin M., Kolodner R.D., and Kucherlapati R. The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res. 60 (2000) 803-807
20. Fodde R., Edelmann W., Yang K., van Leeuwen C., Carlson C., Renault B., Breukel C., Alt E., Lipkin M., Khan P.M., et al. A targeted chain termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA 91 (1994) 8969-8973
21. Gould K.A., Dietrich W.F., Borenstein N., Lander E.S., and Dove W.F. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics 144 (1996) 1769-1776
22. Gould K.A., and Dove W.F. Action of min and mom1 on neoplasia in ectopic intestinal grafts. Cell Growth Differ. 7 (1996) 1361-1368
23. Gould K.A., Luongo C., Moser A.R., McNeley M.K., Borenstein N., Shedlovsky A., Dove W.F., Hong K., Dietrich W.F., and Lander E.S. Genetic evaluation of candidate genes for the mom1 modifier of intestinal neoplasia in mice. Genetics 144 (1996) 1777-1785
24. Haigis K.M., and Dove W.F. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat. Genet. 33 (2003) 33-39
25. min/+ mom1s mice. Proc. Natl. Acad. Sci. USA 102 (2005) 2868-2873
26. Halberg R.B., Katzung D.S., Hoff P.D., Moser A.R., Cole C.E., Lubet R.A., Donehower L.A., Jacoby R.F., and Dove W.F. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. Proc. Natl. Acad. Sci. USA 97 (2000) 3461-3466
27. Hamamoto T., Beppu H., Okada H., Kawabata M., Kitamura T., Miyazono K., and Kato M. Compound disruption of smad2 accelerates malignant progression of intestinal tumors in Apc knockout mice. Cancer Res. 62 (2002) 5955-5961
28. Hanson C.A., and Miller J.R. Non-traditional roles for the Adenomatous polyposis coli (APC) tumor suppressor protein. Gene 361 (2005) 1-12
29. Hinoi T., Akyol A., Theisen B.K., Ferguson D.O., Greenson J.K., Williams B.O., Cho K.R., and Fearon E.R. Mouse model of colonic adenomacarcinoma progression based on somatic Apc inactivation. Cancer Res. 67 (2007) 9721-9730
30. Min mice. Mol. Cell Biol. 24 (2004) 7598-7611
31. Khanna C., and Hunter K. Modeling metastasis in vivo. Carcinogenesis 26 (2005) 513-523
32. Kucherlapati M., Yang K., Kuraguchi M., Zhao J., Lia M., Heyer J., Kane M.F., Fan K., Russell R., Brown A.M., Kneitz B., Edelmann W., Kolodner R.D., Lipkin M., and Kucherlapati R. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression. Proc. Natl. Acad. Sci. USA 99 (2002) 9924-9929
33. 1638N mice reveal a mutational signature of Mlh1 deficiency. Oncogene 19 (2000) 5755-5763
34. 1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis. Cancer Res. 61 (2001) 7934-7942
35. Kuraguchi M., Wang X.P., Bronson R.T., Rothenberg R., Ohene-Baah N.Y., Lund J.J., Kucherlapati M., Maas R.L., and Kucherlapati R. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet. 2 (2006) e146
36. Kwong L.N., Shedlovsky A., Biehl B.S., Clipson L., Pasch C.A., and Dove W.F. Identification of Mom7, a novel modifier of Apc (Min/+) on mouse chromosome 18. Genetics 176 (2007) 1237-1244
37. Li Q., Ishikawa T.O., Oshima M., and Taketo M.M. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Cancer Res. 65 (2005) 8622-8627
38. Lin H., Yamada Y., Nguyen S., Linhart H., Jackson-Grusby L., Meissner A., Meletis K., Lo G., and Jaenisch R. Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol. Cell Biol. 26 (2006) 2976-2983
39. Luo G., Santoro I.M., McDaniel L.D., Nishijima I., Mills M., Youssoufian H., Vogel H., Schultz R.A., and Bradley A. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26 (2000) 424-429
40. Min-induced intestinal neoplasia. Cell 81 (1995) 957-966
41. Mazelin L., Bernet A., Bonod-Bidaud C., Pays L., Arnaud S., Gespach C., Bredesen D.E., Scoazec J.Y., and Mehlen P. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431 (2004) 80-84
42. Moser A.R., Pitot H.C., and Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247 (1990) 322-324
43. Moser A.R., Dove W.F., Roth K.A., and Gordon J.I. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol. 116 (1992) 1517-1526
44. Nagase H., and Nakamura Y. Mutations of the APC (Adenomatous polyposis coli) gene. Hum. Mutat. 2 (1993) 425-434
45. Nathke I.S. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu. Rev. Cell Dev. Biol. 20 (2004) 337-366
46. Olive K.P., and Tuveson D.A. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin. Cancer Res. 12 (2006) 5277-5287
47. Oshima H., Oshima M., Kobayashi M., Tsutsumi M., and Taketo M.M. Morphological and molecular processes of polyp formation in Apc (delta716) knockout mice. Cancer Res. 57 (1997) 1644-1649
48. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., and Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92 (1995) 4482-44826
49. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., and Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803-809
50. Oshima M., and Taketo M.M. COX selectivity and animal models for colon cancer. Curr. Pharm. Des. 8 (2002) 1021-1034
51. Philipp-Staheli J., Kim K.H., Payne S.R., Gurley K.E., Liggitt D., Longton G., and Kemp C.J. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 1 (2002) 355-368
52. 1638N mice with a mutant Apc allele. Am. J. Pathol. 163 (2003) 1757-1763
53. Quesada C.F., Kimata H., Mori M., Nishimura M., Tsuneyoshi T., and Baba S. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Jpn. J. Cancer Res. 89 (1998) 392-396
54. Min/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc. Natl. Acad. Sci. USA 102 (2005) 4365-4370
55. Reitmair A.H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.W., Wakeham A., Liu B., et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet. 11 (1995) 64-70
56. Reitmair A.H., Cai J.C., Bjerknes M., Redston M., Cheng H., Pind M.T., Hay K., Mitri A., Bapat B.V., Mak T.W., and Gallinger S. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56 (1996) 2922-2926
57. Rowan A.J., Lamlum H., Ilyas M., Wheeler J., Straub J., Papadopoulou A., Bicknell D., Bodmer W.F., and Tomlinson I.P. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc. Natl. Acad. Sci. USA 97 (2000) 3352-3357
58. Rudolph K.L., Millard M., Bosenberg M.W., and DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28 (2001) 155-159
59. Sansom O.J., Berger J., Bishop S.M., Hendrich B., Bird A., and Clarke A.R. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat. Genet. 34 (2003) 145-147
60. Sansom O.J., Reed K.R., van de Wetering M., Muncan V., Winton D.J., Clevers H., and Clarke A.R. Cyclin D1 is not an immediate target of betacatenin following Apc loss in the intestine. J. Biol. Chem. 280 (2005) 28463-28467
61. Sansom O.J., Meniel V., Wilkins J.A., Cole A.M., Oien K.A., Marsh V., Jamieson T.J., Guerra C., Ashton G.H., Barbacid M., and Clarke A.R. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc. Natl. Acad. Sci. USA 103 (2006) 14122-14127
62. Sansom O.J., Meniel V.S., Muncan V., Phesse T.J., Wilkins J.A., Reed K.R., Vass J.K., Athineos D., Clevers H., and Clarke A.R. Myc deletion rescues Apc deficiency in the small intestine. Nature 446 (2007) 676-679
63. Sasai H., Masaki M., and Wakitani K. Suppression of polypogenesis in a new mouse strain with a truncated Apc (Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 21 (2000) 953-958
64. Senda T., Iizuka-Kogo A., Onouchi T., and Shimomura A. Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. Med. Mol. Morphol. 40 (2007) 68-81
65. Shibata H., Toyama K., Shioya H., Ito M., Hirota M., Hasegawa S., Matsumoto H., Takano H., Akiyama T., Toyoshima K., Kanamaru R., Kanegae Y., Saito I., Nakamura Y., Shiba K., and Noda T. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278 (1997) 120-123
66. Min/+ mice. Proc. Natl. Acad. Sci. USA 95 (1998) 10826-10831
67. Min/+) mice. Cancer Res. 64 (2004) 8876-8881
68. Silverman K.A., Koratkar R., Siracusa L.D., and Buchberg A.M. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res. 12 (2002) 88-97
69. Silverman K.A., Koratkar R.A., Siracusa L.D., and Buchberg A.M. Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus. Mamm. Genome 14 (2003) 119-129
70. 1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 18 (1997) 321-327
71. 1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114 (1998) 275-283
72. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., Oshima M., and Taketo M.M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc (Delta 716) knockout mice. Nat. Med. 7 (2001) 1048-1051
73. Steinbach G., Lynch P.M., Phillips R.K., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., Su L.K., and Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342 (2000) 1946-1952
74. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., and Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256 (1992) 668-670
75. Suraweera N., Haines J., McCart A., Rogers P., Latchford A., Coster M., Polanco-Echeverry G., Guenther T., Wang J., Sieber O., Tomlinson I., and Silver A. Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice. Hum. Mol. Genet. 15 (2006) 3429-3435
76. Swamy M.V., Patlolla J.M., Steele V.E., Kopelovich L., Reddy B.S., and Rao C.V. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. Cancer Res. 66 (2006) 7370-7377
77. Takeda H., Sonoshita M., Oshima H., Sugihara K., Chulada P.C., Langenbach R., Oshima M., and Taketo M.M. Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res. 63 (2003) 4872-4877
78. Taketo M.M. Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene 25 (2006) 7522-7530
79. Takaku K., Oshima M., Miyoshi H., Matsui M., Seldin M.F., and Taketo M.M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92 (1998) 645-656
80. Tomlinson I.P., Beck N.E., Neale K., and Bodmer W.F. Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours. Ann. Hum. Genet. 60 (1996) 369-376
81. Wallace M.H., and Lynch P.M. The current status of chemoprevention in FAP. Fam. Cancer 5 (2006) 289-294
82. D.E. Watkins-Chow, W.J. Pavan, Genomic copy number and expression variation within the C57BL/6J inbred mouse strain, Genome Res. (2007). Nov 21 e-pub ahead of print.
83. Wong J.J., Hawkins N.J., and Ward R.L. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 56 (2007) 140-148
84. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H., and Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA 102 (2005) 13580-13585